Left CVA with Right Hemiparesis + Uncontrolled Diabetes

1. Understanding the Left CVA - Right Hemiparesis Link

• Right hemiplegia/hemiparesis - face, arm, and leg (arm > leg in MCA territory)
• Aphasia (Broca's = expressive; Wernicke's = receptive; global) - left hemisphere is dominant in ~95% of right-handed individuals
• Right hemisensory loss
• Gaze deviation to the left (eyes deviate toward the lesion in acute large infarcts)
• Right homonymous hemianopia (if posterior limb of internal capsule or optic radiation involved)
• Dysarthria and dysphagia - risk of aspiration pneumonia

2. Impact of Diabetes on This Stroke

• Diabetes increases stroke severity and mortality and predisposes to deep subcortical (lacunar) infarctions due to small-vessel lipohyalinosis
• Hyperglycemia at the time of acute stroke leads to worse outcomes and increased hemorrhagic transformation following thrombolytic therapy
• However - and this is clinically important - aggressively lowering blood glucose acutely after stroke does not clearly improve outcomes. Multiple trials (GIST-UK, SELESTIAL, the SHINE Trial) failed to show benefit for intensive glucose control post-stroke, and intensive control increased hypoglycemia risk
• The target glucose range in acute stroke is generally 140-180 mg/dL - avoid both extremes

3. Acute Medical Management Priorities

Airway & Oxygenation

• Aspiration risk is high - dysphagia occurs in >10% of unilateral hemispheric strokes
• Keep head of bed >30 degrees; NPO until formal swallowing evaluation by speech pathology
• Pulse oximetry; supplemental O2 if SpO2 <94%

Blood Pressure

• Post-stroke BP is often transiently elevated - do not aggressively lower it
• Optimal range: SBP 160-200 / DBP 70-110 mmHg acutely (maintains perfusion in area of impaired autoregulation)
• IV labetalol (10 mg over 1-2 min) if urgent lowering is needed
• Lower more aggressively only if tPA/thrombectomy was given (target <180/105)

Glycemic Control

• Avoid hypoglycemia - this can mimic or worsen stroke and cause permanent injury
• Avoid hyperglycemia >180-200 mg/dL - use insulin infusion titrated cautiously
• Do NOT pursue tight glucose control acutely (increases hypoglycemia risk without benefit)
• In the long term, good glycemic control is essential to prevent recurrence through control of atherosclerosis, small-vessel disease, and HTN

Cardiac Monitoring

• ECG + troponin on admission; monitor for 48 hours
• Atrial fibrillation is a common precipitant of embolic left MCA stroke - requires anticoagulation if confirmed

Antiplatelet / Anticoagulation

• Aspirin 160-325 mg within 48 hours (IST and CAST trials: reduces early recurrence and mortality with small but real net benefit)
• Dual antiplatelet therapy (aspirin + clopidogrel) for 21 days after minor stroke or TIA (high-risk period)
• Routine anticoagulation (heparin) is NOT indicated for atherothrombotic stroke - no benefit, increased hemorrhage risk
• Exception: anticoagulate if atrial fibrillation confirmed as etiology

4. Managing Uncontrolled Diabetes in This Context

• GLP-1 receptor agonists (e.g., semaglutide, liraglutide): reduce MACE including stroke - a 2025 meta-analysis of 99,599 patients (PMID 40892610) confirmed cardiovascular benefit
• SGLT-2 inhibitors (empagliflozin, canagliflozin): cardiovascular and renal protection
• Metformin: first-line for T2DM if renal function adequate
• Pioglitazone: may reduce recurrent stroke/MI in insulin-resistant non-diabetic stroke patients, but weight gain and edema limit use

• HbA1c < 7-7.5% for most patients
• Less stringent targets (< 8%) in elderly or those with recurrent hypoglycemia

5. Rehabilitation of Right Hemiparesis

• Stroke unit care with specialized nursing reduces mortality and improves outcomes
• Start physical therapy (PT), occupational therapy (OT), and speech therapy (SLP) early
• Prevent complications of immobility: DVT (use pneumatic compression stockings), pressure sores, contractures, aspiration pneumonia
• Constraint-induced movement therapy (CIMT): immobilizing the unaffected arm forces use of the paretic arm - proven to improve hemiparesis even years after stroke by recruiting unused neural pathways
• AFO (ankle-foot orthosis): assists foot drop and knee clearance, enabling earlier ambulation
• SSRIs: may help prevent post-stroke depression (common after left hemisphere stroke), with possible (controversial) motor recovery benefit
• Emerging: robotic therapy, transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS) - under active investigation

6. Secondary Prevention

Key Clinical Alerts

• Hypoglycemia can cause stroke-like symptoms or worsen neurologic deficits - always check blood glucose in any neurologic change
• Dysphagia is a major immediate risk - no oral intake until cleared by SLP
• DVT/PE risk is high with hemiplegia and immobility - prophylaxis is mandatory
• Monitor for post-stroke depression (very common after left hemisphere stroke with aphasia)